Page 156 - Glucose Monitoring Devices

157
References

[56] Battelino T, et al. The use and efficacy of continuous glucose monitoring in type 1 dia-
betes treated with insulin pump therapy: a randomised controlled trial. Diabetologia
2012;55:3155e62.
[57] Battelino T, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1
diabetes. Diabetes Care 2011;34:795e800.
[58] van Beers CA, et al. Continuous glucose monitoring for patients with type 1 diabetes
and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label,
crossover trial. The Lancet Diabetes and Endocrinology 2016;4:893e902.
[59] Heinemann L, et al. Real-time continuous glucose monitoring in adults with type 1 dia-
betes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with
multiple daily insulin injections (HypoDE): a multicentre, randomised controlled
trial. Lancet 2018;391:1367e77.
[60] Murphy HR, et al. Improved pregnancy outcomes in women with type 1 and type 2
diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Dia-
betologia 2017;60:1668e77.
[61] Murphy HR, et al. Effectiveness of continuous glucose monitoring in pregnant women
with diabetes: randomised clinical trial. BMJ 2008;337:a1680.
[62] Feig DS, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes
(CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017;
390:2347e59.
[63] Vloemans AF, et al. Keeping safe. Continuous glucose monitoring (CGM) in persons
with type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.
Diabetic Medicine 2017;34:1470e6.
[64] Polonsky WH, Fisher L, Hessler D, Edelman SV. What is so tough about self-
monitoring of blood glucose? Perceived obstacles among patients with type 2
diabetes. Diabetic Medicine 2014;31:40e6.
[65] Kerssen A, de Valk HW, Visser GH. Day-to-day glucose variability during pregnancy
in women with type 1 diabetes mellitus: glucose profiles measured with the continuous
glucose monitoring system. BJOG 2004;111:919e24.
[66] Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-
adjunct use of continuous glucose monitoring. Diabetes Technology and Therapeutics
2015;17:177e86.
[67] Shivers JP, Mackowiak L, Anhalt H, Zisser H. “Turn it off!”: diabetes device alarm
fatigue considerations for the present and the future. Journal of Diabetes Science
and Technology 2013;7:789e94.
[68] Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R. Novel glucose-
sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked,
randomised controlled trial. Lancet 2016;388:2254e63.
[69] Haak T, et al. Flash glucose-sensing technology as a replacement for blood glucose
monitoring for the management of insulin-treated type 2 diabetes: a multicenter,
open-label randomized controlled trial. Diabetes Therapy 2017;8:55e73.
[70] Reddy M, Jugnee N, Anantharaja S, Oliver N. Switching from flash glucose moni-
toring to continuous glucose monitoring on hypoglycemia in adults with type 1 dia-
betes at high hypoglycemia risk: the extension phase of the I HART CGM study.
Diabetes Technology and Therapeutics 2018;20:751e7.